{"id":"W3039669474","doi":"10.1002/ijc.33137","title":"Characterization of a dual <scp>BET</scp>/<scp>HDAC</scp> inhibitor for treatment of pancreatic ductal adenocarcinoma","year":2020,"lang":"en","type":"article","venue":"International Journal of Cancer","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":52,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Novartis Pharma; Deutschen Konsortium für Translationale Krebsforschung; Ministero dello Sviluppo Economico; Genome Canada; Fundação de Amparo à Pesquisa do Estado de São Paulo; Deutsche Forschungsgemeinschaft; Ontario Ministry of Economic Development and Innovation; European Synchrotron Radiation Facility; Wellcome Trust; European Federation of Pharmaceutical Industries and Associations; Merck KGaA; Deutsche Krebshilfe; Pfizer","keywords":"Bromodomain; BRD4; BET inhibitor; Cancer research; Epigenetics; Chemistry; Chromatin; Biology; Pharmacology; Biochemistry; Gene","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001680179,0.0002988811,0.0002788799,0.0002652806,0.0001175513,0.0001903988,0.0003321711,0.00023121,0.001071051],"category_scores_gemma":[0.0001535725,0.0001462465,0.000196355,0.0002105208,0.0001007718,0.0001655885,0.0001444929,0.0003886707,0.0003942199],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002748823,"about_ca_system_score_gemma":0.0003250464,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005050388,"about_ca_topic_score_gemma":0.00127432,"domain_scores_codex":[0.9998947,0.00001273385,0.00001000255,0.00001878388,0.00004443619,0.00001930206],"domain_scores_gemma":[0.9999341,0.00000723887,0.00001376014,0.000006943571,0.00001258537,0.00002543178],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0001637857,0.00008664696,0.0002250257,0.00002693907,0.00001317055,0.00004627553,0.000006826423,0.0003330802,0.9934505,0.00005771911,0.00005885078,0.00553114],"study_design_scores_gemma":[0.000134742,0.001639946,0.002725131,0.000003685805,0.00004111971,0.0004871779,0.000006062926,0.001551366,0.9882884,0.00002718448,0.00509013,0.000004950889],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9876344,0.001772521,0.007168132,0.0001233341,0.00002557882,0.0002476267,0.0006457003,0.00007927867,0.002303529],"genre_scores_gemma":[0.9839697,0.001514322,0.008602219,0.00008436637,0.00001614035,0.0001282452,0.001958863,0.00004033045,0.003685862],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001071051,"threshold_uncertainty_score":0.003583074,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01638396802171311,"score_gpt":0.2740297099845431,"score_spread":0.25764574196283,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}